Literature DB >> 11264351

Degradation of p21cip1 in cells productively infected with human cytomegalovirus.

Z Chen1, E Knutson, A Kurosky, T Albrecht.   

Abstract

Human cytomegalovirus (HCMV) stimulates arrested cells to enter the cell cycle by activating cyclin-dependent kinases (Cdks), notably Cdk2. Several mechanisms are involved in the activation of Cdk2. HCMV causes a substantial increase in the abundance of cyclin E and stimulates translocation of Cdk2 from the cytoplasm to the nucleus. Further, the abundance of the Cdk inhibitors (CKIs) p21cip1/waf1 (p21cip1) and p27kip1 is substantially reduced. The activity of cyclin E/Cdk2 increases as levels of CKIs, particularly p21cip1, fall. We have previously shown that these phenomena contribute to priming the cell for efficient replication of HCMV. In this study, the mechanisms responsible for the decrease in p21cip1 levels after HCMV infection were investigated by measuring p21cip1 RNA and protein levels in permissive human lung (LU) fibroblasts after HCMV infection. Northern blot analysis revealed that p21cip1 RNA levels increased briefly at 3 h after HCMV infection and then decreased to their nadir at 24 h; thereafter, RNA levels increased to about 60% of the preinfection level. Western blot analysis demonstrated that the relative abundance of p21cip1 protein roughly paralleled the observed changes in initial RNA levels; however, the final levels of protein were much lower than preinfection levels. After a transient increase at 3 h postinfection, p21cip1 abundance declined sharply over the next 24 h and remained at a very low level through 96 h postinfection. The disparity between p21cip1 RNA and protein levels suggested that the degradation of p21cip1 might be affected in HCMV-infected cells. Treatment of HCMV-infected cells with MG132, an inhibitor of proteasome-mediated proteolysis, provided substantial protection of p21cip1 in mock-infected cells, but MG132 was much less effective in protecting p21cip1 in HCMV-infected cells. The addition of E64d or Z-Leu-Leu-H, each an inhibitor of calpain activity, to HCMV-infected cells substantially increased the abundance of p21cip1 in a concentration-dependent manner. To verify that p21cip1 was a substrate for calpain, purified recombinant p21cip1 was incubated with either m-calpain or mu-calpain, which resulted in rapid proteolysis of p21cip1. E64d inhibited the proteolysis of p21cip1 catalyzed by either m-calpain or mu-calpain. Direct measurement of calpain activity in HCMV-infected LU cells indicated that HCMV infection induced a substantial and sustained increase in calpain activity, although there was no change in the abundance of either m- or mu-calpain or the endogenous calpain inhibitor calpastatin. The observed increase of calpain activity was consistent with the increases in intracellular free Ca2+ and phospholipid degradation in HCMV-infected LU cells reported previously from our laboratory. Considered together, these results suggest that the increase in calpain activity observed following HCMV infection contributes significantly to the reduction of p21cip1 levels and the resultant cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264351      PMCID: PMC114853          DOI: 10.1128/JVI.75.8.3613-3625.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  92 in total

Review 1.  Inhibitors of mammalian G1 cyclin-dependent kinases.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

Review 2.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

Review 3.  Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

Authors:  T Hunter; J Pines
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

4.  Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest.

Authors:  F M Jault; J M Jault; F Ruchti; E A Fortunato; C Clark; J Corbeil; D D Richman; D H Spector
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21.

Authors:  V N Podust; L M Podust; F Goubin; B Ducommun; U Hübscher
Journal:  Biochemistry       Date:  1995-07-11       Impact factor: 3.162

6.  Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21.

Authors:  Z Q Pan; J T Reardon; L Li; H Flores-Rozas; R Legerski; A Sancar; J Hurwitz
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

7.  p21-containing cyclin kinases exist in both active and inactive states.

Authors:  H Zhang; G J Hannon; D Beach
Journal:  Genes Dev       Date:  1994-08-01       Impact factor: 11.361

Review 8.  Cdk inhibitors: on the threshold of checkpoints and development.

Authors:  S J Elledge; J W Harper
Journal:  Curr Opin Cell Biol       Date:  1994-12       Impact factor: 8.382

Review 9.  Mammalian G1 cyclins.

Authors:  G F Draetta
Journal:  Curr Opin Cell Biol       Date:  1994-12       Impact factor: 8.382

10.  Inhibition of cyclin-dependent kinases by p21.

Authors:  J W Harper; S J Elledge; K Keyomarsi; B Dynlacht; L H Tsai; P Zhang; S Dobrowolski; C Bai; L Connell-Crowley; E Swindell
Journal:  Mol Biol Cell       Date:  1995-04       Impact factor: 4.138

View more
  41 in total

1.  Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase.

Authors:  Chun-Jen Chen; Kazuo Sugiyama; Hideyuki Kubo; Cheng Huang; Shinji Makino
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 2.  Is HCMV a tumor promoter?

Authors:  Liliana Soroceanu; Charles S Cobbs
Journal:  Virus Res       Date:  2010-10-29       Impact factor: 3.303

3.  Consensus on the role of human cytomegalovirus in glioblastoma.

Authors:  Kristine Dziurzynski; Susan M Chang; Amy B Heimberger; Robert F Kalejta; Stuart R McGregor Dallas; Martine Smit; Liliana Soroceanu; Charles S Cobbs
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

4.  Cyclin-dependent kinase activity is required for efficient expression and posttranslational modification of human cytomegalovirus proteins and for production of extracellular particles.

Authors:  Veronica Sanchez; Deborah H Spector
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Cell cycle arrest by human cytomegalovirus 86-kDa IE2 protein resembles premature senescence.

Authors:  Emanuela Noris; Claudia Zannetti; Anna Demurtas; John Sinclair; Marco De Andrea; Marisa Gariglio; Santo Landolfo
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Human Cytomegalovirus nuclear egress and secondary envelopment are negatively affected in the absence of cellular p53.

Authors:  Man I Kuan; John M O'Dowd; Kamila Chughtai; Ian Hayman; Celeste J Brown; Elizabeth A Fortunato
Journal:  Virology       Date:  2016-08-05       Impact factor: 3.616

7.  Limoniastrum guyonianum aqueous gall extract induces apoptosis in colorectal cancer cells by inhibiting calpain activity.

Authors:  Mounira Krifa; Antonio Pizzi; Marc Mousli; Leila Chekir-Ghedira; Ludovic Leloup; Kamel Ghedira
Journal:  Tumour Biol       Date:  2014-05-15

8.  Targeted deletion of Capn4 in cells of the chondrocyte lineage impairs chondrocyte proliferation and differentiation.

Authors:  Aki Kashiwagi; Ernestina Schipani; Mikaela J Fein; Peter A Greer; Masako Shimada
Journal:  Mol Cell Biol       Date:  2010-04-05       Impact factor: 4.272

9.  Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response.

Authors:  Jonathan P Castillo; Fiona M Frame; Harry A Rogoff; Mary T Pickering; Andrew D Yurochko; Timothy F Kowalik
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein.

Authors:  Eung-Soo Hwang; Zhigang Zhang; Haobin Cai; David Y Huang; Shu-Mei Huong; Chang-Yong Cha; Eng-Shang Huang
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.